Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Tables)

v3.19.3.a.u2
Stockholders' Deficit (Tables)
6 Months Ended
Dec. 31, 2019
Equity [Abstract]  
Schedule of Stock Warrant Activity

Warrant detail for the six months ended December 31, 2019 is reflected below:

 

   

Number of

Warrants

   

Weighted

Average

Exercise

Price Per

Warrant

   

Remaining

Contract

Term (#

years)

 
Warrants outstanding and exercisable at June 30, 2019     8,333     $ 20.00       0.25  
Warrants issued     -     $ -       -  
Warrants exercised     -     $ -       -  
Warrants forfeited     (8,333 )   $ 20.00       -  
Warrants outstanding and exercisable at December 31, 2019     -     $ -       -  

 

Warrant detail for the six months ended December 31, 2018 is reflected below:

 

   

Number of

Warrants

   

Weighted

Average

Exercise

Price Per

Warrant

   

Remaining

Contract

Term (#

years)

 
Warrants outstanding and exercisable at June 30, 2018     174,079     $ 20.30       0.74  
Warrants issued     -     $ -       -  
Warrants exercised     -     $ -       -  
Warrants exchanged     (7,996 )   $ 14.80       -  
Warrants forfeited     -     $ -       -  
Warrants outstanding and exercisable at December 31, 2018     166,083     $ 20.60       0.19  

Schedule of Stock Options Activity

Activity in stock options during the six months ended December 31, 2019, and related balances outstanding as of that date are reflected below:

 

   

Number of

Shares

   

Weighted

Average

Exercise Price

   

Weighted

Average

Remaining

Contract

Term (# years)

 
Outstanding at June 30, 2019     580,171     $ 11.05       8.59  
Granted     -     $ -          
Exercised     (4,437 )   $ 4.69          
Forfeited and cancelled     (7,093 )   $ 12.32          
Outstanding at December 31, 2019     568,641     $ 11.08       8.07  
Exercisable at December 31, 2019     377,428     $ 10.47       7.71  

 

Activity in stock options during the six months ended December 31, 2018, and related balances outstanding as of that date are reflected below:

 

   

Number of

Shares

   

Weighted

Average

Exercise Price

   

Weighted

Average

Remaining

Contract

Term (# years)

 
Outstanding at June 30, 2018     354,447     $ 8.30       8.87  
Granted     40,117     $ 17.50          
Exercised     -     $ -          
Forfeited and cancelled     (18,000 )   $ 4.60          
Outstanding at December 31, 2018     376,564     $ 9.50       8.48  
Exercisable at December 31, 2018     188,494     $ 8.30       7.69  

Schedule of Stock-Based Compensation Expenses

The Company allocated stock-based compensation expense included in the condensed consolidated statements of operations for employee option grants and non-employee option grants as follows:

 

    For the Three Months
Ended December 31
    For the Six Months
Ended December 31,
 
    2019     2018     2019     2018  
Research and development   $ 54,000     $ 17,000     $ 108,000     $ 32,000  
General and administration     395,000       226,000       792,000       375,000  
Total stock-based compensation expense   $ 449,000     $ 243,000     $ 900,000     $ 407,000  

Schedule of Fair Value Assumptions of Stock Options

The Company uses the Black-Scholes valuation model to calculate the fair value of stock options. The fair value of stock options was measured at the grant date using the assumptions (annualized percentages) in the table below:

 

Six months ended December 31,   2019     2018  
Expected volatility     111.4% - 112.2%       142% - 143%  
Risk free interest rate     2.43% - 2.45%       2.73% - 2.82%  
Forfeiture rate     20.0%       20.0%  
Dividend yield     0%       0%  
Expected term (years)     5.61       5